Cargando…
TNFα inhibitor induced lupus-like syndrome (TAILS) in a patient with IBD
Background: In patients with autoimmune diseases like inflammatory bowel diseases there has been reported a drug-induced lupus like syndrome secondary to TNFα inhibitors. Objective: clinical case presentation and literature review of patients who develop lupus-like syndrome in relation to TNFα antag...
Autores principales: | LUPU, A., TIERANU, C., CONSTANTINESCU, C.L., DICULESCU, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medical University Publishing House Craiova
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709703/ https://www.ncbi.nlm.nih.gov/pubmed/26788358 http://dx.doi.org/10.12865/CHSJ.40.04.11 |
Ejemplares similares
-
Onset of lupus like syndrome in patients with spondyloarthritis treated with anti-TNF-α
por: Puertas-Abreu, Eduardo, et al.
Publicado: (2012) -
Safety of TNF-α inhibitors during IBD pregnancy: a systematic review
por: Nielsen, Ole Haagen, et al.
Publicado: (2013) -
Anti-TNF-α and hydralazine drug-induced lupus
por: Quaresma, Maria Victória, et al.
Publicado: (2015) -
Intestinal microbiota changes induced by TNF-inhibitors in IBD-related spondyloarthritis
por: Ditto, Maria Chiara, et al.
Publicado: (2021) -
Clinical and histological features of lupus nephritis induced by anti-TNFα therapy
por: Piccolo, Tiziana, et al.
Publicado: (2008)